Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3745426016 | Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3745427013 | Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3745428015 | Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3745475015 | Retinoic acid syndrome | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Is a | Sequela | false | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Is a | Disorder of immune function | true | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Is a | Acute promyelocytic leukaemia, FAB M3 | true | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Is a | Complication of procedure | false | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Following | Chemotherapy | true | Inferred relationship | Some | 2 | |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Finding site | Bone marrow structure | true | Inferred relationship | Some | 1 | |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Due to | Chemotherapy | true | Inferred relationship | Some | 3 | |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Associated morphology | Acute promyelocytic leukaemia | true | Inferred relationship | Some | 1 | |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Is a | Complication of chemotherapy | true | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Pathological process | Abnormal immune process | false | Inferred relationship | Some | 4 | |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Is a | Disorder following clinical procedure | false | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Is a | Complication of introduction procedure | true | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Pathological process | Abnormal immune process | true | Inferred relationship | Some | 1 | |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Is a | Haematologic complication of procedure | true | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | Is a | Neoplastic complication of procedure | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian emergency department reference set
Clinical finding foundation reference set
Neoplasm and/or hamartoma reference set
Problem/Diagnosis reference set
FHIR